Knee osteoarthritis (OA) is a heterogeneous disease associated with substantial effects on
quality of life, and its clinical management is difficult. Among the several available guidelines …

Osteoarthritis (OA) is a degenerative disease characterized by loss of articular cartilage and
chronic inflammation, involving multiple cellular dysfunctions and tissue lesions. The non …

Objective To review the current state of pharmaceutical treatment recommendations for the
management of osteoarthritis. Method A narrative review was drafted to describe treatment …

Osteoarthritis (OA) is a widespread chronic degenerative joint disease characterized by the
degeneration of articular cartilage or inflamed joints. Our findings indicated that treatment …

Osteoarthritis (OA) is the most common joint disease, generating pain, disability, and
socioeconomic costs worldwide. Currently there are no approved disease-modifying drugs …

Background: Platelet-rich plasma (PRP) is gaining large interest in clinical practice as a
minimally invasive injective treatment for knee osteoarthritis (OA). Different preparation …

Objective To evaluate the quality of clinical practice guidelines (CPGs) for interventions in
management of osteoarthritis (OA) and to provide a synthesis of high‐quality CPG …

This personal choice of research themes and highlights from within the past year (1 May
2019 to 14 April 2020) spans descriptive, analytical-observational, and intervention studies …

Objectives Guideline adherence for hip and knee osteoarthritis management is often poor,
possibly related to the quality and/or inconsistent recommendations. This systematic review …

Osteoarthritis (OA) is a leading cause of disability among older adults worldwide. Treatment
aims are to alleviate inflammatory pain and improve physical function through non …